Cancer Screening Guideline & Coverage Watch

Why this is recommended

A colonoscopy age that dropped to 45, a follow-up colonoscopy the law now says must be free, a $0 mammogram program, or a blood test that Medicare now covers are each a conversation worth having this month, and the Tab gives the member the sourced sentence to start it.

What the Tab covers

Who it is for

Every adult over 40, everyone with a family history and the people who keep postponing the appointment.

When it runs

Task forces and specialty societies publish mid-week and coverage rules follow their dates

Scope

USPSTF, American Cancer Society, ACOG, ACR, NCCN and specialty society screening recommendations for breast, colorectal, cervical, lung, prostate, skin and other cancers; ACA, Medicare and state coverage rules for screening and follow-up tests; FDA approvals and CMS coverage for at-home, stool, blood-based and imaging tests; free and low-cost screening programs from CDC NBCCEDP, states and health systems; facility accreditation, ratings and recalls; dense breast notification and supplemental imaging rules; state screening coverage laws

Suggested task

The objective your Tab starts with. You can edit every line of it once the Tab is yours.

Screening age, interval and method changes for breast, colon, cervical, lung, prostate and skin cancer from the USPSTF and specialty societies, insurance and Medicare coverage rules for screening and follow-up, at-home and blood-based test approvals and coverage, free and low-cost screening programs, screening facility ratings and recalls, dense breast notification rules and state screening laws, written for patients and never individual advice, with the cancer or program first.

Track cancer screening for US adults, written for patients. Report only confirmed, source-backed items from the last 7 days: screening age, interval, risk-group and method recommendation changes for breast, colorectal, cervical, lung, prostate, skin and other cancers from the USPSTF, the American Cancer Society, ACOG, ACR, NCCN and specialty societies; ACA, Medicare, Medicaid and state coverage rule changes for screening and follow-up tests; FDA approvals and CMS coverage decisions for at-home, stool, blood-based and imaging tests; free and low-cost screening programs from the CDC, states and health systems with eligibility; imaging facility accreditation actions, ratings and equipment recalls; dense breast notification and supplemental imaging rules; and state screening coverage laws taking effect. Prefer USPSTF, CDC, CMS, FDA, specialty societies, peer-reviewed journals and established health reporting; ignore test marketing and unverified claims, state the evidence level, never give individual medical advice and end each finding with a question worth asking a clinician. Put the cancer or program first in the title with what changed. Use high severity for a recommendation change affecting most adults in an age group, a coverage change at Medicare or a national insurer, or a free program with a closing window. Return no more than 6 findings. Push each as a finding with a title, a two-sentence summary, sections for what changed, who it applies to, the evidence level, a question for the clinician, and the source link. If nothing qualifies, push nothing and submit the run receipt.